Monday, 19 December 2011

Metricure




Metricure may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Metricure



Cefapirin

Cefapirin is reported as an ingredient of Metricure in the following countries:


  • Australia

  • New Zealand

Cefapirin benzathine (a derivative of Cefapirin) is reported as an ingredient of Metricure in the following countries:


  • Belgium

  • France

  • Germany

  • Ireland

  • Italy

  • Netherlands

  • Switzerland

  • United Kingdom

International Drug Name Search

Friday, 16 December 2011

MS Wormguard




MS Wormguard may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for MS Wormguard



Flubendazole

Flubendazole is reported as an ingredient of MS Wormguard in the following countries:


  • Netherlands

International Drug Name Search

Tuesday, 13 December 2011

Siccalix




Siccalix may be available in the countries listed below.


Ingredient matches for Siccalix



Dexpanthenol

Dexpanthenol is reported as an ingredient of Siccalix in the following countries:


  • Switzerland

International Drug Name Search

Monday, 5 December 2011

Zomig Nasal




Zomig Nasal may be available in the countries listed below.


Ingredient matches for Zomig Nasal



Zolmitriptan

Zolmitriptan is reported as an ingredient of Zomig Nasal in the following countries:


  • Czech Republic

  • Iceland

  • Luxembourg

  • Norway

  • Sweden

  • Switzerland

International Drug Name Search

Saturday, 3 December 2011

Cardilol




Cardilol may be available in the countries listed below.


Ingredient matches for Cardilol



Carvedilol

Carvedilol is reported as an ingredient of Cardilol in the following countries:


  • Brazil

  • Tunisia

International Drug Name Search

Thursday, 1 December 2011

Fenemal Recip




Fenemal Recip may be available in the countries listed below.


Ingredient matches for Fenemal Recip



Phenobarbital

Phenobarbital is reported as an ingredient of Fenemal Recip in the following countries:


  • Iceland

  • Sweden

International Drug Name Search

Friday, 25 November 2011

Benzocaïne




Benzocaïne may be available in the countries listed below.


Ingredient matches for Benzocaïne



Benzocaine

Benzocaïne (DCF) is known as Benzocaine in the US.

International Drug Name Search

Glossary

DCFDénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 24 November 2011

Gentamycin Augensalbe




Gentamycin Augensalbe may be available in the countries listed below.


Ingredient matches for Gentamycin Augensalbe



Gentamicin

Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Gentamycin Augensalbe in the following countries:


  • Germany

International Drug Name Search

Sunday, 20 November 2011

Falergi




Falergi may be available in the countries listed below.


Ingredient matches for Falergi



Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Falergi in the following countries:


  • Indonesia

International Drug Name Search

Saturday, 19 November 2011

PK-Merz-Schoeller




PK-Merz-Schoeller may be available in the countries listed below.


Ingredient matches for PK-Merz-Schoeller



Amantadine

Amantadine sulfate (a derivative of Amantadine) is reported as an ingredient of PK-Merz-Schoeller in the following countries:


  • Austria

International Drug Name Search

Wednesday, 16 November 2011

Erythromycin Base Filmtab




Ingredient matches for Erythromycin Base Filmtab



Erythromycin

Erythromycin is reported as an ingredient of Erythromycin Base Filmtab in the following countries:


  • United States

International Drug Name Search

Tuesday, 15 November 2011

Fosfacid




Fosfacid may be available in the countries listed below.


Ingredient matches for Fosfacid



Alendronic Acid

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Fosfacid in the following countries:


  • Mexico

International Drug Name Search

Sunday, 13 November 2011

Lopred




Lopred may be available in the countries listed below.


Ingredient matches for Lopred



Loteprednol

Loteprednol etabonate (a derivative of Loteprednol) is reported as an ingredient of Lopred in the following countries:


  • Argentina

International Drug Name Search

Friday, 11 November 2011

Fenticonazolo




Fenticonazolo may be available in the countries listed below.


Ingredient matches for Fenticonazolo



Fenticonazole

Fenticonazolo (DCIT) is also known as Fenticonazole (Rec.INN)

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, 9 November 2011

Fluconazol Krka




Fluconazol Krka may be available in the countries listed below.


Ingredient matches for Fluconazol Krka



Fluconazole

Fluconazole is reported as an ingredient of Fluconazol Krka in the following countries:


  • Denmark

  • Finland

  • Norway

  • Sweden

International Drug Name Search

Sunday, 6 November 2011

Novagel




Novagel may be available in the countries listed below.


Ingredient matches for Novagel



Aluminium Hydroxide

Aluminium Hydroxide is reported as an ingredient of Novagel in the following countries:


  • Oman

Magnesium Carbonate

Magnesium Carbonate is reported as an ingredient of Novagel in the following countries:


  • Oman

Magnesium Hydroxide

Magnesium Hydroxide is reported as an ingredient of Novagel in the following countries:


  • Oman

International Drug Name Search

Acide flavodique




Acide flavodique may be available in the countries listed below.


Ingredient matches for Acide flavodique



Flavodic Acid

Acide flavodique (DCF) is also known as Flavodic Acid (Rec.INN)

International Drug Name Search

Glossary

DCFDénomination Commune Française
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, 4 November 2011

Fenamide




Fenamide may be available in the countries listed below.


Ingredient matches for Fenamide



Diclofenamide

Diclofenamide is reported as an ingredient of Fenamide in the following countries:


  • Italy

International Drug Name Search

Thursday, 3 November 2011

Opelansol




Opelansol may be available in the countries listed below.


Ingredient matches for Opelansol



Lansoprazole

Lansoprazole is reported as an ingredient of Opelansol in the following countries:


  • Vietnam

International Drug Name Search

Amisulpride Sandoz




Amisulpride Sandoz may be available in the countries listed below.


Ingredient matches for Amisulpride Sandoz



Amisulpride

Amisulpride is reported as an ingredient of Amisulpride Sandoz in the following countries:


  • Australia

  • France

International Drug Name Search

Tuesday, 1 November 2011

Citegin




Citegin may be available in the countries listed below.


Ingredient matches for Citegin



Gemcitabine

Gemcitabine is reported as an ingredient of Citegin in the following countries:


  • Slovakia

International Drug Name Search

Friday, 28 October 2011

Ofoxin




Ofoxin may be available in the countries listed below.


Ingredient matches for Ofoxin



Ciprofloxacin

Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Ofoxin in the following countries:


  • Brazil

International Drug Name Search

Thursday, 27 October 2011

Sufentanil Narcomed




Sufentanil Narcomed may be available in the countries listed below.


Ingredient matches for Sufentanil Narcomed



Sufentanil

Sufentanil citrate (a derivative of Sufentanil) is reported as an ingredient of Sufentanil Narcomed in the following countries:


  • Hungary

International Drug Name Search

Monday, 24 October 2011

Suminat




Suminat may be available in the countries listed below.


Ingredient matches for Suminat



Sumatriptan

Sumatriptan succinate (a derivative of Sumatriptan) is reported as an ingredient of Suminat in the following countries:


  • India

International Drug Name Search

Thursday, 20 October 2011

Ameride




Ameride may be available in the countries listed below.


Ingredient matches for Ameride



Amiloride

Amiloride hydrochloride dihydrate (a derivative of Amiloride) is reported as an ingredient of Ameride in the following countries:


  • Spain

International Drug Name Search

Sunday, 16 October 2011

Coropres




Coropres may be available in the countries listed below.


Ingredient matches for Coropres



Carvedilol

Carvedilol is reported as an ingredient of Coropres in the following countries:


  • Spain

International Drug Name Search

Saturday, 15 October 2011

Ratio-Clobetasol


Generic Name: clobetasol (Topical application route)


kloe-BAY-ta-sol PROE-pee-oh-nate


Commonly used brand name(s)

In the U.S.


  • Clobevate

  • Clobex

  • Cormax

  • Embeline

  • Embeline E

  • Embeline Scalp Application

  • Olux

  • Olux/Olux-E Complete Pack

  • Olux-E

  • Temovate

  • Temovate E

In Canada


  • Clobetasol Propionate

  • Dermovate

  • Dermovate Scalp Application

  • Med Clobetasol Scalp Application

  • Ratio-Clobetasol

Available Dosage Forms:


  • Cream

  • Ointment

  • Gel/Jelly

  • Spray

  • Solution

  • Foam

  • Emollient Cream

  • Lotion

  • Shampoo

Therapeutic Class: Corticosteroid, Very Strong


Pharmacologic Class: Clobetasol


Uses For Ratio-Clobetasol


Clobetasol topical is used to help relieve redness, itching, swelling, or other discomfort caused by skin conditions. The solution and foam are used for scalp problems, the lotion and spray are used for moderate to severe plaque psoriasis, and the shampoo is used for moderate to severe scalp psoriasis. This medicine is a corticosteroid (cortisone-like medicine or steroid).


This medicine is available only with your doctor's prescription.


Before Using Ratio-Clobetasol


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of clobetasol topical gel, foam, cream, ointment, or scalp solution in children 12 years of age and older. However, because of this medicine's toxicity, it should be used with caution. Children may absorb large amounts through the skin, which can cause serious side effects. If your child is using this medicine, follow your doctor's instructions very carefully. Safety and efficacy have not been established in children younger than 12 years of age and the use of clobetasol topical gel, foam, cream, ointment, or scalp solution is not recommended. The safety and efficacy of clobetasol topical spray, lotion, or shampoo have not been established in children and use is not recommended.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of clobetasol topical in the elderly.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.


Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Cushing's syndrome (adrenal gland disorder) or

  • Diabetes or

  • Hyperglycemia (high blood sugar) or

  • Intracranial hypertension (increased pressure in the head)—Use with caution. May make these conditions worse.

  • Infection of the skin at or near the place of application or

  • Large sores, broken skin, or severe skin injury at the place of application—The chance of side effects may be increased.

  • Perioral dermatitis (skin problem) or

  • Rosacea (skin problem)—Should not be used in patients with these conditions.

Proper Use of clobetasol

This section provides information on the proper use of a number of products that contain clobetasol. It may not be specific to Ratio-Clobetasol. Please read with care.


It is very important that you use this medicine only as directed by your doctor. Do not use more of it, do not use it more often, and do not use it for a longer time than your doctor ordered. To do so may cause unwanted side effects or skin irritation.


This medicine is for use on the skin only. Do not get it in your eyes, nose, mouth, or vagina. Do not use it on skin areas that have cuts, scrapes, or burns. If it does get on these areas, rinse it off right away with water.


This medicine should only be used for skin conditions that your doctor is treating. Check with your doctor before using it for other conditions, especially if you think that a skin infection may be present. This medicine should not be used to treat certain kinds of skin infections or conditions, such as severe burns.


Do not use this medicine on the face, groin, or underarms unless directed to do so by your doctor.


To use the cream, foam, gel, lotion, ointment, or spray:


  • Wash your hands with soap and water before and after using this medicine.

  • Apply a thin layer of this medicine to the affected area of the skin. Rub it in gently.

  • With the lotion, protect the skin from water, clothing, or anything that causes rubbing until the medicine has dried. Also, shake the lotion well before using it.

  • Do not bandage or otherwise wrap the skin being treated unless directed to do so by your doctor.

To use the foam, scalp solution, or shampoo:


  • Wash your hands with soap and water before and after using this medicine.

  • Apply a thin layer of this medicine to the affected area of the scalp. Rub it in gently.

  • Do not cover the scalp (e.g., shower cap, bathing cap) while it is being treated.

  • Do not use the shampoo for more than 4 weeks, the foam and scalp solution for more than 2 weeks unless your doctor has told you to.

This medicine comes with a patient information insert. Read and follow the instructions in the insert carefully. Ask your doctor if you have any questions.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For redness, itching, and swelling of the skin:
    • For topical dosage forms (cream, gel, or ointment):
      • Adults—Apply to the affected area of the skin two times per day.

      • Children 12 to 17 years of age—Apply to the affected area of the skin two times per day.

      • Children younger than 12 years of age—Use is not recommended.


    • For topical dosage form (lotion):
      • Adults—Apply to the affected area of the skin two times per day.

      • Children—Use is not recommended.



  • For plaque psoriasis:
    • For topical dosage form (foam):
      • Adults—Apply to the affected area of the skin two times per day, once in the morning and once at night.

      • Children 12 to 17 years of age—Apply to the affected area of the skin two times per day, once in the morning and once at night.

      • Children younger than 12 years of age—Use is not recommended.


    • For topical dosage form (spray):
      • Adults—Spray to the affected area of the skin two times per day.

      • Children—Use is not recommended.



  • For scalp problems:
    • For topical dosage form (foam or scalp solution):
      • Adults—Apply to the affected area of the scalp two times per day, once in the morning and once at night.

      • Children 12 to 17 years of age—Apply to the affected area of the scalp two times per day, once in the morning and once at night.

      • Children younger than 12 years of age—Use is not recommended.


    • For topical dosage form (shampoo):
      • Adults—Apply to the affected area of the scalp once a day.

      • Children—Use is not recommended.



Missed Dose


If you miss a dose of this medicine, apply it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule.


Storage


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Store the foam can at room temperature, away from heat and direct light. Do not keep this medicine inside a car where it could be exposed to extreme heat. Do not poke holes in the canister or throw it into a fire, even if the canister is empty.


Precautions While Using Ratio-Clobetasol


It is very important that your doctor check the progress of you or your child at regular visits for any unwanted effects that may be caused by this medicine.


If your or your child's symptoms do not improve within a few days, or if they become worse, check with your doctor.


Using too much of this medicine or using it for a long time may increase your risk of having adrenal gland problems. The risk is greater for children and patients who use large amounts for a long time. Talk to your doctor right away if you or your child have more than one of these symptoms while you are using this medicine: blurred vision; dizziness or fainting; a fast, irregular, or pounding heartbeat; increased thirst or urination; irritability; or unusual tiredness or weakness.


Stop using this medicine and check with your doctor right away if you or your child have a skin rash, burning, stinging, swelling, or irritation on the skin.


Make sure your doctor knows that you are using clobetasol gel. You may need to stop using this medicine several days before having surgery.


Do not use cosmetics or other skin care products on the treated areas.


Ratio-Clobetasol Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


More common
  • Burning or stinging at the application site

Less common
  • Burning sensation of the skin

  • dry skin

  • flushing or redness of the skin

  • itching, scaling, severe redness, soreness, or swelling of the skin

  • skin irritation

  • skin rash, encrusted, scaly and oozing

  • thinning of the skin with easy bruising, especially when used on the face or where the skin folds together (e.g. between the fingers)

Incidence not known
  • Burning, itching, and pain in hairy areas, or pus at the root of the hair

  • hair loss

  • redness and scaling around the mouth

  • thinning of the hair

  • thinning, weakness, or wasting away of the skin

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Cough

  • sore throat

Less common
  • Burning, itching, and pain in hairy areas, or pus at the root of the hair

  • changes in skin coloring

  • body aches or pain

  • congestion

  • cough

  • dryness or soreness of the throat

  • fever

  • headache

  • hoarseness

  • raised, dark red, wart-like spots on the skin, especially when used on the face

  • skin discomfort

  • stuffy or runny nose

  • tender, swollen glands in the neck

  • trouble with swallowing

  • unusual tiredness or weakness

  • voice changes

Incidence not known
  • Acne or pimples

  • burning and itching of the skin with pinhead-sized red blisters

  • increased hair growth on the forehead, back, arms, and legs

  • lightening of normal skin color

  • lightening of treated areas of dark skin

  • reddish purple lines on the arms, face, legs, trunk, or groin

  • softening of the skin

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Ratio-Clobetasol side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Ratio-Clobetasol resources


  • Ratio-Clobetasol Side Effects (in more detail)
  • Ratio-Clobetasol Use in Pregnancy & Breastfeeding
  • Ratio-Clobetasol Drug Interactions
  • Ratio-Clobetasol Support Group
  • 48 Reviews for Ratio-Clobetasol - Add your own review/rating


Compare Ratio-Clobetasol with other medications


  • Anal Itching
  • Atopic Dermatitis
  • Cutaneous T-cell Lymphoma
  • Dermatitis
  • Lichen Planus
  • Lichen Sclerosus
  • Necrobiosis Lipoidica Diabeticorum
  • Psoriasis
  • Seborrheic Dermatitis

Vitamina C Genfar




Vitamina C Genfar may be available in the countries listed below.


Ingredient matches for Vitamina C Genfar



Ascorbic Acid

Ascorbic Acid is reported as an ingredient of Vitamina C Genfar in the following countries:


  • Chile

  • Colombia

  • Ecuador

International Drug Name Search

Tuesday, 11 October 2011

Fengdaxin




Fengdaxin may be available in the countries listed below.


Ingredient matches for Fengdaxin



Ceftazidime

Ceftazidime is reported as an ingredient of Fengdaxin in the following countries:


  • China

International Drug Name Search

Sunday, 9 October 2011

Symlosin SR




Symlosin SR may be available in the countries listed below.


Ingredient matches for Symlosin SR



Tamsulosin

Tamsulosin hydrochloride (a derivative of Tamsulosin) is reported as an ingredient of Symlosin SR in the following countries:


  • Poland

International Drug Name Search

Friday, 7 October 2011

Ofloxacin-Teva




Ofloxacin-Teva may be available in the countries listed below.


Ingredient matches for Ofloxacin-Teva



Ofloxacin

Ofloxacin is reported as an ingredient of Ofloxacin-Teva in the following countries:


  • Israel

International Drug Name Search

Saturday, 1 October 2011

Oraceftin




Oraceftin may be available in the countries listed below.


Ingredient matches for Oraceftin



Cefuroxime

Cefuroxime axetil (a derivative of Cefuroxime) is reported as an ingredient of Oraceftin in the following countries:


  • Turkey

International Drug Name Search

Friday, 30 September 2011

Prednisone Richard




Prednisone Richard may be available in the countries listed below.


Ingredient matches for Prednisone Richard



Prednisone

Prednisone is reported as an ingredient of Prednisone Richard in the following countries:


  • France

International Drug Name Search

Wednesday, 28 September 2011

Ventrosteril




Ventrosteril may be available in the countries listed below.


Ingredient matches for Ventrosteril



Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Ventrosteril in the following countries:


  • Georgia

International Drug Name Search

Monday, 26 September 2011

Bromazépam Arrow




Bromazépam Arrow may be available in the countries listed below.


Ingredient matches for Bromazépam Arrow



Bromazepam

Bromazepam is reported as an ingredient of Bromazépam Arrow in the following countries:


  • France

International Drug Name Search

Wednesday, 21 September 2011

Lozar




Lozar may be available in the countries listed below.


Ingredient matches for Lozar



Losartan

Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Lozar in the following countries:


  • Bangladesh

International Drug Name Search

Tuesday, 20 September 2011

Acadrex




Acadrex may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Acadrex



Fenvalerate

Fenvalerate is reported as an ingredient of Acadrex in the following countries:


  • France

International Drug Name Search

Sunday, 18 September 2011

Pulmicort Turbuhaler


See also: Generic Pulmicort Flexhaler, Generic Pulmicort Respules


Pulmicort Turbuhaler is a brand name of budesonide, approved by the FDA in the following formulation(s):


PULMICORT (budesonide - powder, metered; inhalation)



  • Manufacturer: ASTRAZENECA

    Approval date: June 24, 1997

    Strength(s): 0.16MG/INH [RLD]

Has a generic version of Pulmicort Turbuhaler been approved?


No. There is currently no therapeutically equivalent version of Pulmicort Turbuhaler available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Pulmicort Turbuhaler. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Pulmicort Turbuhaler.

See also...

  • Pulmicort Consumer Information (Drugs.com)
  • Pulmicort Turbuhaler Powder Consumer Information (Wolters Kluwer)
  • Pulmicort Advanced Consumer Information (Micromedex)
  • Pulmicort Oral Advanced Consumer Information (Micromedex)
  • Pulmicort Turbuhaler Advanced Consumer Information (Micromedex)
  • Budesonide Powder Consumer Information (Wolters Kluwer)
  • Budesonide Suspension Consumer Information (Wolters Kluwer)
  • Budesonide Sustained-Release Capsules Consumer Information (Wolters Kluwer)
  • Budesonide Consumer Information (Cerner Multum)
  • Budesonide inhalation Consumer Information (Cerner Multum)
  • Pulmicort Spacer Advanced Consumer Information (Micromedex)
  • Rhinocort Turbuhaler Advanced Consumer Information (Micromedex)
  • Budesonide Advanced Consumer Information (Micromedex)
  • Budesonide Inhalation Advanced Consumer Information (Micromedex)
  • Budesonide AHFS DI Monographs (ASHP)

Monday, 12 September 2011

Topicasone




Topicasone may be available in the countries listed below.


Ingredient matches for Topicasone



Betamethasone

Betamethasone 17α-benzoate (a derivative of Betamethasone) is reported as an ingredient of Topicasone in the following countries:


  • India

International Drug Name Search

Sunday, 11 September 2011

Orelox




Orelox may be available in the countries listed below.


UK matches:

  • Orelox Paediatric Granules for Oral Suspension
  • Orelox Tablets 100mg
  • Orelox Paediatric Granules for Oral Suspension (sanofi-aventis) (SPC)
  • Orelox Tablets 100mg (SPC)

Ingredient matches for Orelox



Cefpodoxime

Cefpodoxime is reported as an ingredient of Orelox in the following countries:


  • Tunisia

Cefpodoxime proxetil (a derivative of Cefpodoxime) is reported as an ingredient of Orelox in the following countries:


  • Benin

  • Brazil

  • Burkina Faso

  • Cameroon

  • Central African Republic

  • Chad

  • Congo

  • Cote D'ivoire

  • France

  • Gabon

  • Germany

  • Guinea

  • Italy

  • Luxembourg

  • Madagascar

  • Mali

  • Malta

  • Mauritania

  • Mauritius

  • Mexico

  • Niger

  • Senegal

  • South Africa

  • Switzerland

  • Togo

  • United Kingdom

  • Zaire

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, 9 September 2011

Rifapin




Rifapin may be available in the countries listed below.


Ingredient matches for Rifapin



Rifampicin

Rifampicin is reported as an ingredient of Rifapin in the following countries:


  • Yemen

International Drug Name Search

Thursday, 8 September 2011

Ovidrel


Generic Name: chorionic gonadotropin (Subcutaneous route, Intramuscular route, Injection route)


kor-ee-ON-ok goe-nad-oh-TROE-pin


Commonly used brand name(s)

In the U.S.


  • Chorex

  • Novarel

  • Ovidrel

  • Pregnyl

  • Profasi

In Canada


  • Chorionic Gonadotropin

Available Dosage Forms:


  • Powder for Solution

  • Solution

Therapeutic Class: Endocrine-Metabolic Agent


Pharmacologic Class: Gonadotropin


Uses For Ovidrel


Chorionic gonadotropin is a drug whose actions are almost the same as those of luteinizing hormone (LH), which is produced by the pituitary gland. It is a hormone also normally produced by the placenta in pregnancy. Chorionic gonadotropin has different uses for females and males.


In females, chorionic gonadotropin is used to help conception occur. It is usually given in combination with other drugs such as menotropins and urofollitropin. Many women being treated with these drugs usually have already tried clomiphene alone (e.g., Serophene) and have not been able to conceive yet. Chorionic gonadotropin is also used in in vitro fertilization (IVF) programs.


In males, LH and chorionic gonadotropin stimulate the testes to produce male hormones such as testosterone. Testosterone causes the enlargement of the penis and testes and the growth of pubic and underarm hair. It also increases the production of sperm.


Although chorionic gonadotropin has been prescribed to help some patients lose weight, it should never be used this way. When used improperly, chorionic gonadotropin can cause serious problems.


Chorionic gonadotropin is to be administered only by or under the immediate supervision of your doctor.


Before Using Ovidrel


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Chorionic gonadotropin, when used for treating cryptorchidism (a birth defect where the testes remain inside the body), has caused the sexual organs of some male children to develop too rapidly.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersXStudies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities. This drug should not be used in women who are or may become pregnant because the risk clearly outweighs any possible benefit.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.


Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Asthma or

  • Epilepsy (seizures) or

  • Heart problems or

  • Kidney problems or

  • Migraine headaches—This medication may worsen these conditions.

  • Cancer of the prostate or

  • Precocious puberty (a condition that causes early puberty in boys before 9 years of age)—Increases in the amount of testosterone in the bloodstream may make these conditions worse.

  • Cyst on ovary or

  • Fibroid tumors of the uterus—Chorionic gonadotropin can cause further growth of cysts on the ovary or fibroid tumors of the uterus

  • Unusual vaginal bleeding—Irregular vaginal bleeding is a sign that the endometrium is growing too much, of endometrial cancer, or of other hormone imbalances; the increases in estrogen production caused by ovulation can aggravate these problems of the endometrium. If other hormone imbalances are present, they should be treated before beginning ovulation induction

Proper Use of chorionic gonadotropin

This section provides information on the proper use of a number of products that contain chorionic gonadotropin. It may not be specific to Ovidrel. Please read with care.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For injection dosage form:
    • For treating men with problems related to low levels of male hormones:
      • Adults—1000 to 4000 Units injected into the muscle two to three times a week. You may need to receive this medicine for several weeks, months, or longer. If you are being treated for a low sperm count and have been on this medicine for six months, your doctor may give you another hormone medicine (menotropin or urofollitropin injection). You may need to receive both of these medicines together for up to twelve more months.


    • To help pregnancy occur in women:
      • Adults—5000 to 10,000 Units injected into the muscle on a day chosen by your doctor. The dose and day will depend on your hormone levels and the other medicines that you have been using.


    • For the treatment of cryptorchidism (condition where testes do not develop properly):
      • Children—1000 to 5000 Units injected into the muscle two to three times a week for up to ten doses.



Precautions While Using Ovidrel


It is very important that your doctor check your progress at regular visits to make sure that the medicine is working and to check for unwanted effects.


For women taking this medicine to become pregnant :


  • Record your basal body temperature every day if told to do so by your doctor, so that you will know if you have begun to ovulate. It is important that intercourse take place around the time of ovulation to give you the best chance of becoming pregnant. Your doctor will likely want to monitor the development of the ovarian follicle(s) by measuring the amount of estrogen in your bloodstream and by checking the size of the follicle(s) with ultrasound examinations.

Ovidrel Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor as soon as possible if any of the following side effects occur:


For females onlyMore common
  • Bloating (mild)

  • stomach or pelvic pain

Less common or rare
  • Abdominal or stomach pain (severe)

  • bloating (moderate to severe)

  • decreased amount of urine

  • feeling of indigestion

  • nausea, vomiting, or diarrhea (continuing or severe)

  • pelvic pain (severe)

  • shortness of breath

  • swelling of feet or lower legs

  • weight gain (rapid)

For boys onlyLess common
  • Acne

  • enlargement of penis and testes

  • growth of pubic hair

  • increase in height (rapid)

Frequency not determined
  • difficult or labored breathing

  • difficulty breathing

  • flushing of skin

  • hives or welts

  • itching of skin

  • large, hive-like swelling on face, eyelids, lips, tongue, throat, hands, legs, feet, sex organs

  • pain in chest, groin, or legs, especially the calves

  • redness of skin

  • severe, sudden headache

  • skin rash

  • slurred speech

  • sudden loss of coordination

  • sudden, severe weakness or numbness in arm or leg

  • sudden, unexplained shortness of breath

  • tightness in chest

  • unusually warm skin

  • vision changes

  • wheezing

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


Less common
  • Discouragement

  • enlargement of breasts

  • feeling sad or empty

  • headache

  • irritability

  • lack of appetite

  • loss of interest or pleasure

  • pain at place of injection

  • trouble concentrating

  • trouble sleeping

  • tiredness

After you stop using this medicine, it may still produce some side effects that need attention. During this period of time, check with your doctor immediately if you notice the following side effects:


For females onlyLess common or rare
  • Abdominal or stomach pain (severe)

  • bloating (moderate to severe)

  • decreased amount of urine

  • feeling of indigestion

  • nausea, vomiting, or diarrhea (continuing or severe)

  • pelvic pain (severe)

  • shortness of breath

  • weight gain (rapid)

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Ovidrel side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Ovidrel resources


  • Ovidrel Side Effects (in more detail)
  • Ovidrel Use in Pregnancy & Breastfeeding
  • Ovidrel Drug Interactions
  • Ovidrel Support Group
  • 1 Review for Ovidrel - Add your own review/rating


  • Ovidrel Prescribing Information (FDA)

  • Ovidrel MedFacts Consumer Leaflet (Wolters Kluwer)

  • Ovidrel Monograph (AHFS DI)

  • Hcg Consumer Overview

  • Novarel MedFacts Consumer Leaflet (Wolters Kluwer)

  • Novarel Prescribing Information (FDA)

  • Pregnyl Prescribing Information (FDA)



Compare Ovidrel with other medications


  • Female Infertility
  • Hypogonadism, Male
  • Ovulation Induction
  • Prepubertal Cryptorchidism

Tuesday, 6 September 2011

Derinox




Derinox may be available in the countries listed below.


Ingredient matches for Derinox



Amoxicillin

Amoxicillin is reported as an ingredient of Derinox in the following countries:


  • Peru

International Drug Name Search

Thursday, 1 September 2011

Kafa




Kafa may be available in the countries listed below.


Ingredient matches for Kafa



Paracetamol

Paracetamol is reported as an ingredient of Kafa in the following countries:


  • Switzerland

International Drug Name Search

Saturday, 27 August 2011

Dislipat




Dislipat may be available in the countries listed below.


Ingredient matches for Dislipat



Atorvastatin

Atorvastatin calcium (a derivative of Atorvastatin) is reported as an ingredient of Dislipat in the following countries:


  • Hungary

International Drug Name Search

Solicam




Solicam may be available in the countries listed below.


Ingredient matches for Solicam



Piroxicam

Piroxicam is reported as an ingredient of Solicam in the following countries:


  • Belgium

  • Luxembourg

International Drug Name Search

Kefox




Kefox may be available in the countries listed below.


Ingredient matches for Kefox



Cefuroxime

Cefuroxime is reported as an ingredient of Kefox in the following countries:


  • Myanmar

International Drug Name Search

Friday, 19 August 2011

Norfen




Norfen may be available in the countries listed below.


Ingredient matches for Norfen



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Norfen in the following countries:


  • Bangladesh

Norfloxacin

Norfloxacin is reported as an ingredient of Norfen in the following countries:


  • Eritrea

  • Ethiopia

  • Kenya

  • Nigeria

  • Tanzania

  • Uganda

  • Zambia

  • Zimbabwe

International Drug Name Search

Wednesday, 17 August 2011

Sonke-Nevirapine




Sonke-Nevirapine may be available in the countries listed below.


Ingredient matches for Sonke-Nevirapine



Nevirapine

Nevirapine is reported as an ingredient of Sonke-Nevirapine in the following countries:


  • South Africa

International Drug Name Search

Tuesday, 16 August 2011

Flunitrazepam Cevallos




Flunitrazepam Cevallos may be available in the countries listed below.


Ingredient matches for Flunitrazepam Cevallos



Flunitrazepam

Flunitrazepam is reported as an ingredient of Flunitrazepam Cevallos in the following countries:


  • Argentina

International Drug Name Search

Thursday, 11 August 2011

Ciprox




Ciprox may be available in the countries listed below.


Ingredient matches for Ciprox



Ciprofloxacin

Ciprofloxacin is reported as an ingredient of Ciprox in the following countries:


  • Bangladesh

  • Bulgaria

  • Iraq

  • Peru

  • Yemen

Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Ciprox in the following countries:


  • Bangladesh

  • Germany

International Drug Name Search

Wednesday, 10 August 2011

Minoxidil Zydus




Minoxidil Zydus may be available in the countries listed below.


Ingredient matches for Minoxidil Zydus



Minoxidil

Minoxidil is reported as an ingredient of Minoxidil Zydus in the following countries:


  • France

International Drug Name Search

Tuesday, 9 August 2011

Biotin Stada




Biotin Stada may be available in the countries listed below.


Ingredient matches for Biotin Stada



Biotin

Biotin is reported as an ingredient of Biotin Stada in the following countries:


  • Germany

International Drug Name Search

Monday, 8 August 2011

Fdgcadpet




Fdgcadpet may be available in the countries listed below.


Ingredient matches for Fdgcadpet



Fludeoxyglucose (18F)

Fludeoxyglucose (18F) is reported as an ingredient of Fdgcadpet in the following countries:


  • Spain

International Drug Name Search

Amlodep




Amlodep may be available in the countries listed below.


Ingredient matches for Amlodep



Amlodipine

Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Amlodep in the following countries:


  • Hungary

International Drug Name Search

Sunday, 7 August 2011

Benoxil




Benoxil may be available in the countries listed below.


Ingredient matches for Benoxil



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Benoxil in the following countries:


  • Bangladesh

Oxybuprocaine

Oxybuprocaine hydrochloride (a derivative of Oxybuprocaine) is reported as an ingredient of Benoxil in the following countries:


  • Japan

  • Taiwan

International Drug Name Search

Deril




Deril may be available in the countries listed below.


Ingredient matches for Deril



Alfacalcidol

Alfacalcidol is reported as an ingredient of Deril in the following countries:


  • Italy

International Drug Name Search

Saturday, 6 August 2011

Cevirin




Cevirin may be available in the countries listed below.


Ingredient matches for Cevirin



Acyclovir

Aciclovir is reported as an ingredient of Cevirin in the following countries:


  • Ethiopia

International Drug Name Search

Wednesday, 27 July 2011

Benocten




Benocten may be available in the countries listed below.


Ingredient matches for Benocten



Diphenhydramine

Diphenhydramine hydrochloride (a derivative of Diphenhydramine) is reported as an ingredient of Benocten in the following countries:


  • Costa Rica

  • Jordan

  • Kuwait

  • Lebanon

  • Qatar

  • Switzerland

  • United Arab Emirates

  • Yemen

International Drug Name Search

Feneticillina




Feneticillina may be available in the countries listed below.


Ingredient matches for Feneticillina



Pheneticillin

Feneticillina (DCIT) is also known as Pheneticillin (Rec.INN)

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Pantoprazol TAD




Pantoprazol TAD may be available in the countries listed below.


Ingredient matches for Pantoprazol TAD



Pantoprazole

Pantoprazole sodium (a derivative of Pantoprazole) is reported as an ingredient of Pantoprazol TAD in the following countries:


  • Germany

International Drug Name Search

Saturday, 23 July 2011

Fibrase




Fibrase may be available in the countries listed below.


Ingredient matches for Fibrase



Pentosan Polysulfate

Pentosan Polysulfate sodium (a derivative of Pentosan Polysulfate) is reported as an ingredient of Fibrase in the following countries:


  • Italy

International Drug Name Search

Flam-X




Flam-X may be available in the countries listed below.


Ingredient matches for Flam-X



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Flam-X in the following countries:


  • Switzerland

International Drug Name Search

Thursday, 21 July 2011

Divifolin




Divifolin may be available in the countries listed below.


Ingredient matches for Divifolin



Calcium Levofolinate

Calcium Levofolinate pentahydrate (a derivative of Calcium Levofolinate) is reported as an ingredient of Divifolin in the following countries:


  • Italy

International Drug Name Search

Tuesday, 19 July 2011

Dompérone




Dompérone may be available in the countries listed below.


Ingredient matches for Dompérone



Domperidone

Domperidone maleate (a derivative of Domperidone) is reported as an ingredient of Dompérone in the following countries:


  • Algeria

International Drug Name Search

Monday, 18 July 2011

Velenium




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Velenium



Sodium Selenite

Sodium Selenite is reported as an ingredient of Velenium in the following countries:


  • United States

Tocopherol, α-

Tocopherol, α- is reported as an ingredient of Velenium in the following countries:


  • United States

International Drug Name Search

Fluidol




Fluidol may be available in the countries listed below.


Ingredient matches for Fluidol



Carbocisteine

Carbocisteine is reported as an ingredient of Fluidol in the following countries:


  • Romania

International Drug Name Search

Sunday, 17 July 2011

Metajex




Metajex may be available in the countries listed below.


Ingredient matches for Metajex



Metoclopramide

Metoclopramide is reported as an ingredient of Metajex in the following countries:


  • India

International Drug Name Search

Nicomolin




Nicomolin may be available in the countries listed below.


Ingredient matches for Nicomolin



Nicomol

Nicomol is reported as an ingredient of Nicomolin in the following countries:


  • Japan

International Drug Name Search

Friday, 15 July 2011

Rotifamin




Rotifamin may be available in the countries listed below.


Ingredient matches for Rotifamin



Amantadine

Amantadine hydrochloride (a derivative of Amantadine) is reported as an ingredient of Rotifamin in the following countries:


  • Japan

International Drug Name Search

Wednesday, 13 July 2011

Dominin




Dominin may be available in the countries listed below.


Ingredient matches for Dominin



Dopamine

Dopamine hydrochloride (a derivative of Dopamine) is reported as an ingredient of Dominin in the following countries:


  • Japan

International Drug Name Search

Tuesday, 12 July 2011

Cifin




Cifin may be available in the countries listed below.


Ingredient matches for Cifin



Ciprofloxacin

Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Cifin in the following countries:


  • Denmark

International Drug Name Search

Monday, 11 July 2011

Radiomiron




Radiomiron may be available in the countries listed below.


Ingredient matches for Radiomiron



Iopamidol

Iopamidol is reported as an ingredient of Radiomiron in the following countries:


  • Chile

International Drug Name Search

Sunday, 10 July 2011

Meclofenoxato




Meclofenoxato may be available in the countries listed below.


Ingredient matches for Meclofenoxato



Meclofenoxate

Meclofenoxato (DCIT) is also known as Meclofenoxate (Rec.INN)

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, 9 July 2011

Losartan Hydrochlorothiazide Ur




Losartan Hydrochlorothiazide Ur may be available in the countries listed below.


Ingredient matches for Losartan Hydrochlorothiazide Ur



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Losartan Hydrochlorothiazide Ur in the following countries:


  • Spain

Losartan

Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Losartan Hydrochlorothiazide Ur in the following countries:


  • Spain

International Drug Name Search

Thursday, 7 July 2011

Sytraz




Sytraz may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Sytraz



Amitraz

Amitraz is reported as an ingredient of Sytraz in the following countries:


  • Portugal

International Drug Name Search

Thursday, 30 June 2011

Felixita




Felixita may be available in the countries listed below.


Ingredient matches for Felixita



Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Felixita in the following countries:


  • Monaco

Gestodene

Gestodene is reported as an ingredient of Felixita in the following countries:


  • Monaco

International Drug Name Search

Sunday, 26 June 2011

Fleegard




Fleegard may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Fleegard



Cyfluthrin

Cyfluthrin is reported as an ingredient of Fleegard in the following countries:


  • South Africa

Pyriproxyfen

Pyriproxyfen is reported as an ingredient of Fleegard in the following countries:


  • South Africa

International Drug Name Search

Wednesday, 22 June 2011

Lisi TAD HCT




Lisi TAD HCT may be available in the countries listed below.


Ingredient matches for Lisi TAD HCT



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Lisi TAD HCT in the following countries:


  • Germany

Lisinopril

Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Lisi TAD HCT in the following countries:


  • Germany

International Drug Name Search

Mayul




Mayul may be available in the countries listed below.


Ingredient matches for Mayul



Terazosin

Terazosin hydrochloride (a derivative of Terazosin) is reported as an ingredient of Mayul in the following countries:


  • Spain

International Drug Name Search

Sunday, 12 June 2011

Gonal-f RFF


See also: Generic Gonal-f, Generic Gonal-f RFF Pen


Gonal-f RFF is a brand name of follicle stimulating hormone, approved by the FDA in the following formulation(s):


GONAL-F RFF (follitropin alfa/beta - injectable; subcutaneous)



  • Manufacturer: EMD SERONO

    Approval date: March 25, 2004

    Strength(s): 75 IU/VIAL [RLD]

Has a generic version of Gonal-f RFF been approved?


No. There is currently no therapeutically equivalent version of Gonal-f RFF available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Gonal-f RFF. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Follicle stimulating hormone and pharmaceutical compositions containing same
    Patent 5,767,067
    Issued: June 16, 1998
    Inventor(s): Arpaia; Guiseppe & Serani; Serenella & Sirna; Antonino & Villa; Stefano
    Assignee(s): Istituto di Ricerca Cesare Serono S.p.A.
    Purification of human FSH from post-menopausal urine gonadogropin using immunochromatography and reverse phase HPLC steps yelds a biologically active hormone which is free from detectable traces of LH and other urinary proteins.
    Patent expiration dates:

    • June 16, 2015
      ✓ 
      Drug substance




  • Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof
    Patent 5,767,251
    Issued: June 16, 1998
    Inventor(s): Reddy; Vermuri B. & Hsiung; Nancy & Beck; Anton K. & Bernstine; Edward George
    Assignee(s): Genzyme Corporation
    Biologically active heterodimeric human fertility hormones composed of two different subunits, each subunit being synthesized in the same cell transformed by at least one cell expression vector having heterologous DNA encoding each subunit with each subunit being controlled by a separate promoter. Preferred human fertility hormones include hCG, hLH and hFSH.
    Patent expiration dates:

    • June 16, 2015
      ✓ 
      Drug substance



See also...

  • Gonal-f RFF Consumer Information (Cerner Multum)
  • Gonal-f RFF Subcutaneous Advanced Consumer Information (Micromedex)
  • Follitropin Alfa Powder Consumer Information (Wolters Kluwer)
  • Follitropin Alfa Solution Consumer Information (Wolters Kluwer)
  • Follitropin Beta Consumer Information (Wolters Kluwer)
  • Follicle stimulating hormone Consumer Information (Cerner Multum)
  • Follitropin alfa Subcutaneous Advanced Consumer Information (Micromedex)
  • Follitropin beta Subcutaneous Advanced Consumer Information (Micromedex)

Thyrozol




Thyrozol may be available in the countries listed below.


Ingredient matches for Thyrozol



Thiamazole

Thiamazole is reported as an ingredient of Thyrozol in the following countries:


  • Bulgaria

  • Chile

  • China

  • Czech Republic

  • Germany

  • Indonesia

  • Latvia

  • Lithuania

  • Luxembourg

  • Peru

  • Poland

  • Romania

  • Russian Federation

  • Singapore

International Drug Name Search

Thursday, 9 June 2011

Alarex




Alarex may be available in the countries listed below.


Ingredient matches for Alarex



Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Alarex in the following countries:


  • Bangladesh

International Drug Name Search

Sunday, 5 June 2011

Tiopronina




Tiopronina may be available in the countries listed below.


Ingredient matches for Tiopronina



Tiopronin

Tiopronina (DCIT) is known as Tiopronin in the US.

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Phenol




In some countries, this medicine may only be approved for veterinary use.

Scheme

USAN

ATC (Anatomical Therapeutic Chemical Classification)

C05BB05,D08AE03,N01BX03,R02AA19

CAS registry number (Chemical Abstracts Service)

0000108-95-2

Chemical Formula

C6-H6-O

Molecular Weight

94

Therapeutic Categories

Disinfectant

Anesthetic, local

Analgesic

Pharmaceutic aid: Preservative

Sclerosing agent

Agent for local antivaricose therapy

Antipsoriatic

Chemical Name

Phenol

Foreign Names

  • Phenolum (Latin)
  • Phenol (German)
  • Phénol (French)

Generic Names

  • Phenol (OS: JAN)
  • Acid carbolique (IS)
  • AI3 01814 (IS)
  • Benzenol (IS)
  • Carbolic acid (IS)
  • Caswell No.649 (IS)
  • CCRIS 504 (IS)
  • CTFA 02288 (IS)
  • Dentogene (IS: GenicotHoussia)
  • EINECS 203-632-7 (IS)
  • EPA Pesticide Chemical Code 064001 (IS)
  • FEMA No.3223 (IS)
  • HSDB 113 (IS)
  • Hydroxybenzene (IS)
  • Izal (IS)
  • NCI C50124 (IS)
  • NSC 36808 (IS)
  • Oxybenzene (IS)
  • Phenic acid (IS)
  • Phenylic acid (IS)
  • PhOH (IS)
  • RCRA waste number U188 (IS)
  • Phenol (PH: BP 2010, USP 32, Ph. Eur. 6)
  • Phénol (PH: Ph. Eur. 6)
  • Phenolum (PH: Ph. Eur. 6)

Brand Names

  • Anaemex Iron (Phenol and Iron Polymaltose (veterinary use))
    Ausrichter, Australia


  • Camphenic (Phenol and Camphor)
    Agusa Nippon, Japan


  • Cepastat
    Sanofi-Aventis, Hong Kong


  • Diluant Physiologique Phenole
    Stallergenes, Tunisia


  • Fenolo Marco Nova Argentia (Phenol and Glycerol)
    Nova Argentia, Italy


  • Fenolo Marco Viti (Phenol and Glycerol)
    Marco Viti, Italy


  • Fenolo Zeta (Phenol and Glycerol)
    Zeta, Italy


  • Mastidina Pomada (veterinary use)
    Ceva, Portugal


  • Murakami Camphenic (Phenol and Camphor)
    Agusa Nippon, Japan


  • Noraver
    Tecnoquimicas, Colombia


  • Oily Phenol Injection
    MaCarthys, Malta; Mayne, Hong Kong; Phebra, Australia


  • Oily Phenol
    AFT, New Zealand; UCB Pharma, United Kingdom


  • Ozonol Ointment (Phenol and Zinc Oxide)
    Bayer, Canada


  • Paoscle
    Torii Yakuhin, Japan


  • Phenol
    MidWest, New Zealand


  • Phenolated Water
    Nikko Seiyaku, Japan


  • Prephen
    Orion, New Zealand


  • Sore Throat
    Pharmaceutical Associates, United States

International Drug Name Search

Glossary

ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Femtrace




In the US, Femtrace (estradiol systemic) is a member of the drug class estrogens and is used to treat Postmenopausal Symptoms.

US matches:

  • Femtrace

Ingredient matches for Femtrace



Estradiol

Estradiol acetate (a derivative of Estradiol) is reported as an ingredient of Femtrace in the following countries:


  • United States

International Drug Name Search

Tuesday, 31 May 2011

Tiadénol




Tiadénol may be available in the countries listed below.


Ingredient matches for Tiadénol



Tiadenol

Tiadénol (DCF) is also known as Tiadenol (Rec.INN)

International Drug Name Search

Glossary

DCFDénomination Commune Française
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.